AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CELLDEX THERAPEUTICS, INC. · Biotechnology company developing therapeutics for patients.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Issues related to NIH-funded eosinophilic gastrointestinal disease research; Issues related to mast cell conditions and therapies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.